Advertisement

End of Life Care for the Glioma Patient

  • Roeline PasmanEmail author
  • Hanneke Zwinkels
  • Lara Fritz
Chapter

Abstracts

The definition of palliative care is explored in this chapter—it includes ‘end of life’ care, which is defined as care that is given in the last months of life of a patient. End of life care is of great importance for patients with a glioma since the disease trajectory is often accompanied with burdensome symptoms. Survival after diagnosis is relatively short, and the disease can influence patients’ decision-making capacity. Above that, the disease often also has a major impact on relatives of the patient.

In this chapter we will describe the most common physical symptoms in the last months of life of patients with a glioma, and the impact the disease can have on daily life including the psychosocial and spiritual part of life. We will focus on the role of specialist nurses in the last months of life, illustrating the many challenges a nurse can face when caring for a patient with a glioma.

Keywords

Palliative care End of life care Neuro-oncology management Advance care planning Terminal care Dying 

References

  1. 1.
  2. 2.
    Zwinkels H. Grief, bereavement and mourning. Eur Assoc Neuroncol. 2013;3:70–1.Google Scholar
  3. 3.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.CrossRefGoogle Scholar
  4. 4.
    Pace A, Dirven L, Koekkoek JAF, et al. European Association of Neuro-Oncology palliative care task force. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017;18(6):e330–40.CrossRefGoogle Scholar
  5. 5.
    Grant R, Brown PD. Fatigue randomized controlled trials – how tired is “too tired” in patients undergoing glioma treatment? Neuro-Oncology. 2016;18:759–60.CrossRefGoogle Scholar
  6. 6.
    Walbert T, Chasteen K. Palliative and supportive care for glioma patients. In: Raizer J, Parsa A, editors. Current understanding and treatment of gliomas. Cancer Research and treatment volume 163. Dordrecht: Springer; 2015.Google Scholar
  7. 7.
    Armstrong TS, Gilbe MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro-Oncology. 2012;14(Suppl 4):iv65–72.CrossRefGoogle Scholar
  8. 8.
    Sizoo EM, Braam AM, Postma TJ, et al. Symptoms in the end-of-life phase of high grade glioma patients. Neuro Oncol. 2010;12:1162–6.CrossRefGoogle Scholar
  9. 9.
    Rooney AG, McNamare S, Mackinnon M, et al. Frequency, clinical associations, and longitudinal course of major depressive disorders in adults with cerebral glioma. J Clin Oncol. 2011;29:4307–12.CrossRefGoogle Scholar
  10. 10.
    Sizoo EM, Koekkoek JA, Postma TJ, Heimans JJ, Pasman HR, Deliens L, Taphoorn MJ, Reijneveld JC. Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase. BMJ Support Palliat Care. 2014;4:77–80.CrossRefGoogle Scholar
  11. 11.
    Lorenz KA. Progress in quality-of-care research and hope for supportive cancer care. J Clin Oncol. 2008;26(23):3821–3.CrossRefGoogle Scholar
  12. 12.
    Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.CrossRefGoogle Scholar
  13. 13.
    Andreassen P, Neergaard MA, Brogaard T, Skorstengaard MH, Jensen AB. The diverse impact of advance care planning: a long-term follow-up study on patients’ and relatives’ experiences. BMJ Support Palliat Care. 2015;7:335–40.PubMedGoogle Scholar
  14. 14.
    Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.CrossRefGoogle Scholar
  15. 15.
    Kirchhoff KT, Hammes BJ, Kehl KA, Briggs LA, Brown RL. Effect of a disease-specific advance care planning intervention on end-of-life care. J Am Geriatr Soc. 2012;60(5):946–50.CrossRefGoogle Scholar
  16. 16.
    Walbert T. Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neurooncol Pract. 2014;1:3–7.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ, Deliens L, Grant R, McNamara S, Grisold W, Medicus E, Stockhammer G, Oberndorfer S, Flechl B, Marosi C, Taphoorn MJ, Heimans JJ. End of life care in high-grade glioma patients in three European countries: a comparative study. J Neuro-Oncol. 2014;120(2):303–10.CrossRefGoogle Scholar
  18. 18.
    Flechl B, Ackerl M, Sax C, Oberndorfer S, Calabek B, Sizoo E, Reijneveld J, Crevenna R, Keilani M, Gaiger A, Dieckmann K, Preusser M, Taphoorn MJ, Marosi C. The caregivers’ perspective on the end-of-life phase of glioblastoma patients. J Neuro-Oncol. 2013;112(3):403–11.CrossRefGoogle Scholar
  19. 19.
    Sizoo EM, Taphoorn MJ, Uitdehaag B, Heimans JJ, Deliens L, Reijneveld JC, Pasman HR. The end-of-life phase of high-grade glioma patients: dying with dignity? Oncologist. 2013;18(2):198–203.CrossRefGoogle Scholar
  20. 20.
    Kerrigan S, Erridg S, Liaquat I, Graham C, Grant R. Mental incapacity in patients undergoing neuro-oncologic treatment: a cross-sectional study. Neurology. 2014;83:537–41.CrossRefGoogle Scholar
  21. 21.
    Sizoo EM, Pasman HR, Buttolo J, Heimans JJ, Klein M, Deliens L, Reijneveld JC, Taphoorn MJ. Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer. 2012;48:226–32.CrossRefGoogle Scholar
  22. 22.
    Fritz L, Dirven L, Reijneveld JC, Koekkoek JA, Stiggelbout AM, Pasman HR, Taphoorn MJ. Advance care planning in glioblastoma patients. Cancers (Basel). 2016;8(11):pii:E102.CrossRefGoogle Scholar
  23. 23.
  24. 24.
  25. 25.
  26. 26.
    Van Hoose L, Black LL, Doty K, Sabata D, Twumasi-Ankrah P, Taylor S, Johnson R. An analysis of the distress thermometer problem list and distress in patients with cancer. Support Care Cancer. 2015;23:1225–32.CrossRefGoogle Scholar
  27. 27.
    Cavers D, Hacking B, Erridge SE, Kendall M, Morris PG, Murray SA. Social, psychological and existential well-being in patients with glioma and their caregivers: a qualitative study. CMAJ. 2012;184(7):E373–82.CrossRefGoogle Scholar
  28. 28.
    Applebaum AJ, Kryza-Lacombe M, Buthorn J, DeRosa S, Corner G, Diamond EA. Existential distress among caregivers of patients with brain tumours: a review of the literature. Neurooncol Pract. 2016;3:232–44.Google Scholar
  29. 29.
    Robinson BC. Validation of a caregiver strain index. J Gerontol. 1983;3:344–8.CrossRefGoogle Scholar
  30. 30.
  31. 31.
    Aoun S, Toye C, Deas K, Howting D, Ewing G, Grande G, Stajduhar K. Enabling a family caregiver-led assessment of support needs in home-based palliative care: Potential translation into practice. Palliat Med. 2015;29:929–38.CrossRefGoogle Scholar
  32. 32.
    De Korte-Verhoef MC, Pasman HR, Schweitzer BP, Francke AL, Onwuteaka-Philipsen BD, Deliens L. Burden for family carers at the end of life; a mixed-method study of the perspectives of family carers and GPs. BMC Palliat Care. 2014;13(1):16.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Public and Occupational Health, Expertise Center for Palliative Care, Amsterdam Public Health Research InstituteAmsterdam UMC, Vrije Universiteit AmsterdamAmsterdamThe Netherlands
  2. 2.Department of NeurologyHaaglanden Medical Center, AntoniushoveLeidschendamThe Netherlands

Personalised recommendations